Skip to main content
. 2018 Apr 27;15(6):5205–5214. doi: 10.3892/etm.2018.6107

Table I.

Association between miR-142-3p expression and clinicopathological characteristics of patients with ovarian cancer.

Variable Cases (n=58) Low miR-142-3p (n=32) High miR-142-3p (n=26) P-value
Age, years 0.594
  ≤55 22 11 11
  >55 36 21 15
Differentiation 0.027a
  Well/moderately 37 16 21
  Poor 21 16 5
Lymph node metastasis 0.156
  Present 17 12 5
  Absent 41 20 21
Clinical stage 0.113
  I–II 33 15 18
  III–IV 25 17 8
a

P<0.05. miR, microRNA.